Search Clinical Trials Search
Clinical Trials
× ...
Sort & Filter
Sort by
Specialty

Disease or Condition

Age Group


Drug/Medication


382 results found


Other

REGN9933 AND REGN7508 For Prevention of Venous Thromboembolism

The study is focused on adults undergoing a placement of a catheter in their vein, also called a PICC (peripherally inserted central catheter) line, which is used to deliver drugs into the bloodstream, such as ...


Anus, Breast, Colon, Corpus Uteri, Esophagus, Eye and Orbit, Kidney ...

Bristol-Myers Squibb, CA2360001, Ph 1/2, Open-Label, Multi-center, NSCLC, BMS-986482, Solid Tumor

Primary : To assess the safety and tolerability of oral BMS-986482, as monotherapy or in combination with nivolumab SC, nivolumab + relatlimab FDC SC, or bevacizumab, to establish the MTD,MAD, and/or RP2D(s) in participants with advanced solid ...


Liver

SIRT with Tremelimumab and Durvalumab for Resectable Hepatocellular Carcinoma

This study focuses on people who have liver cancer (hepatocellular carcinoma-HCC) for which they will be undergoing surgical treatment. The purpose of the study is to evaluate the safety and tolerability of neoadjuvant treatment (treatment ...


Lung

ECOG/ACRIN, EA5231, Ph3, Rand, NSCLC, durvalumab +/- AZD6738 (ceralasertib)

Primary Objective 2.1.1 The primary objective will be to assess for improvement in disease free survival (DFS) in patients who do not achieve pCR (pathologic complete response) following neoadjuvant therapy and patients who receive adjuvant combination ...


Lung

SWOG, S2414, Ph3, randomized, NSCLC, durvalumab (MEDI4736) versus surveillance.

Primary Objective: To compare disease free survival (DFS) in stage II-IIIB non-small cell lung cancer participants who achieved a pathologic complete response (pCR) following standard of care neoadjuvant chemo-immunotherapy and are randomized to adjuvant ...